Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease

406Citations
Citations of this article
267Readers
Mendeley users who have this article in their library.

Abstract

Copyright © 2016 Massachusetts Medical Society.BACKGROUND: The discovery of low-frequency coding variants affecting the risk of coronary artery disease has facilitated the identification of therapeutic targets. METHODS: Through DNA genotyping, we tested 54,003 coding-sequence variants covering 13,715 human genes in up to 72,868 patients with coronary artery disease and 120,770 controls who did not have coronary artery disease. Through DNA sequencing, we studied the effects of loss-of-function mutations in selected genes. RESULTS: We confirmed previously observed significant associations between coronary artery disease and low-frequency missense variants in the genes LPA and PCSK9. We also found significant associations between coronary artery disease and low-frequency missense variants in the genes SVEP1 (p.D2702G; minor-allele frequency, 3.60%; odds ratio for disease, 1.14; P = 4.2×10-10) and ANGPTL4 (p.E40K; minorallele frequency, 2.01%; odds ratio, 0.86; P = 4.0×10-8), which encodes angiopoietin-like 4. Through sequencing of ANGPTL4, we identified 9 carriers of loss-of-function mutations among 6924 patients with myocardial infarction, as compared with 19 carriers among 6834 controls (odds ratio, 0.47; P = 0.04); carriers of ANGPTL4 loss-of-function alleles had triglyceride levels that were 35% lower than the levels among persons who did not carry a loss-of-function allele (P = 0.003). ANGPTL4 inhibits lipoprotein lipase; we therefore searched for mutations in LPL and identified a loss-of-function variant that was associated with an increased risk of coronary artery disease (p.D36N; minor-allele frequency, 1.9%; odds ratio, 1.13; P = 2.0×10-4) and a gain-of-function variant that was associated with protection from coronary artery disease (p.S447∗; minor-allele frequency, 9.9%; odds ratio, 0.94; P = 2.5×10-7). CONCLUSIONS: We found that carriers of loss-of-function mutations in ANGPTL4 had triglyceride levels that were lower than those among noncarriers; these mutations were also associated with protection from coronary artery disease. (Funded by the National Institutes of Health and others).

References Powered by Scopus

Sequence variations in PCSK9, low LDL, and protection against coronary heart disease

2760Citations
N/AReaders
Get full text

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

2510Citations
N/AReaders
Get full text

A comprehensive 1000 Genomes-based genome-wide association meta-analysis of coronary artery disease

1794Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Heart disease and stroke statistics—2020 update a report from the American Heart Association

6503Citations
N/AReaders
Get full text

Heart disease and stroke statistics - 2018 update: A report from the American Heart Association

5721Citations
N/AReaders
Get full text

Heart Disease and Stroke Statistics-2022 Update: A Report from the American Heart Association

3767Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

(2016). Coding Variation in ANGPTL4, LPL, and SVEP1 and the Risk of Coronary Disease. New England Journal of Medicine, 374(12), 1134–1144. https://doi.org/10.1056/nejmoa1507652

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 78

45%

Researcher 53

31%

Professor / Associate Prof. 36

21%

Lecturer / Post doc 6

3%

Readers' Discipline

Tooltip

Medicine and Dentistry 78

43%

Biochemistry, Genetics and Molecular Bi... 58

32%

Agricultural and Biological Sciences 42

23%

Pharmacology, Toxicology and Pharmaceut... 5

3%

Article Metrics

Tooltip
Mentions
Blog Mentions: 1
News Mentions: 7
References: 1
Social Media
Shares, Likes & Comments: 19

Save time finding and organizing research with Mendeley

Sign up for free